307
Views
0
CrossRef citations to date
0
Altmetric
Meta-analysis

Survival Outcome and Clinicopathologicl analysis of Homeobox gene cluster-embedded LncRNAs in Human Cancers: A Systematic Review and Meta-analysis

, , , , , , , & show all
Pages 1211-1221 | Received 17 Apr 2021, Accepted 17 Aug 2021, Published online: 02 Sep 2021

References

  • Marzhoseyni Z, Shojaie L. Streptococcal bacterial components in cancer therapy. Cancer Gene Ther. 2021 Mar 22.
  • Mirzaei H, Hamblin MR. Regulation of Glycolysis by Non-coding RNAs in Cancer: switching on the Warburg Effect. Mol Ther Oncolytics. 2020 Dec;16(19):218–239.
  • Mirzaei HR, Sahebkar A, Salehi R, et al. Boron neutron capture therapy: moving toward targeted cancer therapy. J Cancer Res Ther. 2016 Apr-Jun;12(2):520–525.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
  • Siegel RL, Miller KD. Cancer statistics, 2020. CA: a cancer journal for clinicians. 2020 Jan;70(1):7–30
  • Kim TK, Hemberg M, Gray JM. Enhancer RNAs: a class of long noncoding RNAs synthesized at enhancers. Cold Spring Harb Perspect Biol. 2015 Jan 5;7(1):a018622.
  • Lee JT. Epigenetic regulation by long noncoding RNAs. Science (New York, NY). 2012 Dec 14;338(6113):1435–1439.
  • Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016 Jan;17(1):47–62.
  • Vafadar A, Shabaninejad Z, Movahedpour A, et al., Long Non-Coding RNAs As Epigenetic Regulators in Cancer. Curr Pharm Des. 25(33): 3563–3577. 2019.
  • Shafabakhsh R, Arianfar F, Vosough M, et al. Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance. 2021 Jan 11.
  • Razavi ZS, Tajiknia V, Majidi S, et al. Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles. Crit Rev Oncol Hematol. 2021;157:103192.
  • Hashemian SM, Pourhanifeh MH, Fadaei S, et al. Non-coding RNAs and Exosomes: their Role in the Pathogenesis of Sepsis. Mol Ther Nucleic Acids. 2020 Sep;4(21):51–74.
  • Wang P, Zhi H, Zhang Y, et al. miRSponge: a manually curated database for experimentally supported miRNA sponges and ceRNAs. Database : the journal of biological databases and curation. 2015;2015:1–7
  • Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011 Aug 5;146(3):353–358.
  • Zhu KP, Zhang CL, Ma XL, et al. Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance. Mol Ther. 2019 Mar 6;27(3):518–530.
  • Hashemipour M, Boroumand H, Mollazadeh S, et al. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Gynecol Oncol. 2021 Apr;161(1):314–327.
  • Apiou F, Flagiello D, Cillo C, et al., Fine mapping of human HOX gene clusters. Cytogenet Cell Genet. 73(1–2): 114–115. 1996.
  • Boncinelli E, Mallamaci A, Lavorgna G. Vertebrate homeobox genes. Genetica. 1994;94(2–3):127–140.
  • Cillo C, Faiella A, Cantile M, et al. Homeobox genes and cancer. Exp Cell Res. 1999 Apr 10;248(1):1–9.
  • Mallo M. Reassessing the Role of Hox Genes during Vertebrate Development and Evolution. Trends Genet. 2018 Mar;34(3):209–217.
  • Cillo C, Barba P, Freschi G, et al. HOX gene expression in normal and neoplastic human kidney. Int J Cancer. 1992 Jul 30;51(6):892–897.
  • Sheth R, Gregoire D, Dumouchel A, et al. Decoupling the function of Hox and Shh in developing limb reveals multiple inputs of Hox genes on limb growth. Development. 2013 May;140(10):2130–2138.
  • Shiraishi M, Sekiguchi A, Oates AJ, et al. HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas. Oncogene. 2002 May 16;21(22):3659–3662.
  • Makiyama K, Hamada J, Takada M, et al. Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep. 2005 Apr;13(4):673–679.
  • Kurscheid S, Bady P, Sciuscio D, et al. Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma. Genome Biol. 2015 Jan 27;16:16.
  • Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007 Jun 29;129(7):1311–1323.
  • Li L, Zhang X, Liu Q, et al. Emerging role of HOX genes and their related long noncoding RNAs in lung cancer. Crit Rev Oncol Hematol. 2019 Jul;139:1–6.
  • Botti G, De Chiara A, Di Bonito M, et al. Noncoding RNAs within the HOX gene network in tumor pathogenesis and progression. Journal of cellular physiology. 2018 Jan;234(1):395–413
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clin Res Ed). 2009 Jul 21;339:b2535.
  • Wang C, Li Y, Li YW, et al. HOTAIR lncRNA SNPs rs920778 and rs1899663 are associated with smoking, male gender, and squamous cell carcinoma in a Chinese lung cancer population. Acta Pharmacol Sin. 2018 Nov;39(11):1797–1803.
  • Lewis EB. A gene complex controlling segmentation in Drosophila. Nature. 1978 Dec 7;276(5688):565–570.
  • Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010 May;10(5):361–371.
  • Manak JR, Scott MP. A class act: conservation of homeodomain protein functions. Dev (Cambridge, England) Supplement. 1994;61–77. https://doi.org/10.1242/dev.1994.Supplement.61
  • Tatangelo F, Di Mauro A, Scognamiglio G, et al. Posterior HOX genes and HOTAIR expression in the proximal and distal colon cancer pathogenesis. J Transl Med. 2018 Dec 12;16(1):350.
  • Lee K, Chang JW, Oh C et al. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/beta-catenin signaling axis. Eur J Surg Oncol. 201912:Dec.
  • Li X, Pang L. LncRNA HOTAIRM1/HOXA1 Axis Promotes Cell Proliferation, Migration And Invasion In Endometrial Cancer. OncoTargets and therapy. 2019;12:10997–11015
  • Zhang Y, Yuan Y, Li Y, et al. An inverse interaction between HOXA11 and HOXA11-AS is associated with cisplatin resistance in lung adenocarcinoma. 2019 Oct;14(10):949–960.
  • Zhang GJ, Song W, Song Y. Overexpression of HOTTIP promotes proliferation and drug resistance of lung adenocarcinoma by regulating AKT signaling pathway. Eur Rev Med Pharmacol Sci. 2017 Dec;21(24):5683–5690.
  • Wang H, Zhang G, Zhang H, et al. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/beta-catenin/Snail signaling pathway. Eur J Pharmacol. 2014 Jan;15(723):156–166.
  • Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3ʹ kinase/AKT pathways. Oncogene. 2005 Nov 14;24(50):7443–7454.
  • Ding J, Xie M, Lian Y, et al. Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer. Oncogenesis. 2017 Jan 23;6(1): e288.
  • Sun M, Nie F, Wang Y, et al. LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1. Cancer Res. 2016 Nov 1;76(21):6299–6310.
  • Tian X, Ma J, Wang T, et al. Long Non-Coding RNA HOXA Transcript Antisense RNA Myeloid-Specific 1-HOXA1 Axis Downregulates the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells in Lung Cancer. Front Immunol. 2018;9:473.
  • Huang JZ, Chen M, Chen D, et al. A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth. Mol Cell. 2017 Oct 5;68(1):171–184.e6.
  • Zhuang XH, Liu Y, Li JL, Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway. 2019 Aug. 30. 39(8)
  • Jiang W, Kai J, Li D, et al. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway. 2020 Oct;235(10):7194–7203.
  • Chen X, Li LQ, Qiu X, et al. Long non-coding RNA HOXB-AS1 promotes proliferation, migration and invasion of glioblastoma cells via HOXB-AS1/miR-885-3p/HOXB2 axis. Neoplasma. 2019 May 23;66(3):386–396.
  • Liu D, Qiu M, Jiang L, et al. Long Noncoding RNA HOXB-AS1 Is Upregulated in Endometrial Carcinoma and Sponged miR-149-3p to Upregulate Wnt10b. Technology in cancer research & treatment. 2020 Jan-Dec;19: 1533033820967462
  • Xu S, Jia G, Zhang H, et al. LncRNA HOXB-AS3 promotes growth, invasion and migration of epithelial ovarian cancer by altering glycolysis. Life Sci. 2021 Jan 1;264:118636.
  • Huang HH, Chen FY, Chou WC, et al. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome. BMC Cancer. 2019 Jun 24;19(1):617.
  • Liu Y, Chen X, Chen X, et al. Long non-coding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93/ATG12 axis in colorectal cancer. Cell Death Dis. 2020 Mar 6;11(3):175.
  • Wang W, Wu D, He X, et al. CCL18-induced HOTAIR upregulation promotes malignant progression in esophageal squamous cell carcinoma through the miR-130a-5p-ZEB1 axis. Cancer Lett. 2019 Sep 28;460:18–28.
  • Battistelli C, Sabarese G, Santangelo L, et al. The lncRNA HOTAIR transcription is controlled by HNF4alpha-induced chromatin topology modulation. Cell Death Differ. 2019 May;26(5):890–901.
  • Tang Q, Zheng F, Liu Z, et al. Novel reciprocal interaction of lncRNA HOTAIR and miR-214-3p contribute to the solamargine-inhibited PDPK1 gene expression in human lung cancer. Journal of cellular and molecular medicine. 2019 Nov;23(11):7749–7761
  • Sun YJ, Li J, Chen CH. Effects of miR-221 on the apoptosis of non-small cell lung cancer cells by lncRNA HOTAIR. Eur Rev Med Pharmacol Sci. 2019 May;23(10):4226–4233.
  • Chen SS, Peng M, Zhou GZ, et al. Long non-coding RNA HOTAIR regulates the development of non-small cell lung cancer through miR-217/DACH1 signaling pathway. Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):670–678.
  • Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014 Apr 28;13:92.
  • Zhao Y, Tang X, Huang Y. Interaction Of c-Jun And HOTAIR- Increased Expression Of p21 Converge In Polyphyllin I-Inhibited Growth Of Human Lung Cancer Cells. 2019;12:10115–10127.
  • Zhang K, Zhou Y, Feng G, et al. [MRTF-A Regulates the Proliferation and Migration of Non-small Cell Lung Cancer Cells of A549 through HOTAIR]. Zhongguo Fei Ai Za Zhi. 2019 Feb 20;22(2):82–89.
  • Ge XS, Ma HJ, Zheng XH, et al. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci. 2013 Dec;104(12):1675–1682.
  • Fang S, Shen Y, Chen B, et al. H3K27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the lncRNA HOTAIR. Ann Transl Med. 2018 Nov;6(22):440.
  • Fang S, Gao H, Tong Y, et al. Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells. Lab Invest. 2016 Jan;96(1):60–68.
  • Kogo R, Shimamura T, Mimori K, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011 Oct 15;71(20):6320–6326.
  • Guo F, Cao Z, Guo H, et al. The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway. Exp Ther Med. 2018 Jun;15(6):4885–4889.
  • Yang Y, Jiang C, Yang Y, et al. Silencing of LncRNA-HOTAIR decreases drug resistance of Non-Small Cell Lung Cancer cells by inactivating autophagy via suppressing the phosphorylation of ULK1. Biochem Biophys Res Commun. 2018 Mar 18;497(4):1003–1010.
  • Liu Z, Sun M, Lu K, et al. The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression. PloS One. 2013;8(10):e77293.
  • Li P, Zhang X, Wang L, et al. lncRNA HOTAIR Contributes to 5FU Resistance through Suppressing miR-218 and Activating NF-κB/TS Signaling in Colorectal Cancer. Mol Ther Nucleic Acids. 2017 Sep 15;8:356–369.
  • Li W, Zhu Q, Zhang S, et al. HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis. Oral Oncol. 2020 Dec;111:104946.
  • Gao C, Lu W, Lou W, et al. Long noncoding RNA HOXC13-AS positively affects cell proliferation and invasion in nasopharyngeal carcinoma via modulating miR-383-3p/HMGA2 axis. J Cell Physiol. 2019 Aug;234(8):12809–12820.
  • Liu N, Wang Z, Liu D, et al. HOXC13-AS-miR-122-5p-SATB1-C-Myc feedback loop promotes migration, invasion and EMT process in glioma. Onco Targets Ther. 2019;12:7165–7173.
  • Xiong D, Wu W, Kan L, et al. LINC00958 and HOXC13-AS as key candidate biomarkers in head and neck squamous cell carcinoma by integrated bioinformatics analysis. PeerJ. 2020;8:e8557.
  • Zhou JF, Shi YT, Wang HG, et al. Overexpression of long noncoding RNA HOXC13-AS and its prognostic significance in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7369–7374.
  • Wang Q, Jiang S, Song A, et al. HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a. Onco Targets Ther. 2017;10:4753–4763.
  • Xia H, Jing H, Li Y, et al. Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis. Biomed Pharmacothe. 2018 Oct;106:156–162.
  • Li Y, Han X, Li Q, et al. Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421. Journal of cellular biochemistry. 2019 Jun;120(6):10633–10642
  • Lu S, Zhou J, Sun Y, et al. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma. Mol Cancer. 2017 Jul 19;16(1):125.
  • Guo X, Chen Z, Zhao L, et al. Long non-coding RNA-HAGLR suppressed tumor growth of lung adenocarcinoma through epigenetically silencing E2F1. Exp Cell Res. 2019 Sep 1;382(1):111461.
  • Ye Y, Yang S, Han Y, et al. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2. Open Biol. 2019 Sep 27;9(9):190068.
  • Gu P, Chen X, Xie R, et al. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5. Mol Ther. 2017 Aug 2;25(8):1959–1973.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.